Sélectionnez l'édition
Pays
Objectif principal
Maladie
Type d'Organisation
Partie prenante
Qualité
Advocacy (policy advocacy, lobbying)
Pharmaceutical, Biotech, Medical Device Company (0)
Researchers (investigators and academic researchers)
Representativeness of stakeholders
Clinical study phase II